Safety of TNF-α inhibitors during IBD pregnancy: a systematic review (Q27008090)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

systematic review

1 reference

PubMed publication ID

2 references

1 February 2021

28 October 2022

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

6 March 2020

main subject

3 references

13 December 2019

1 February 2021

28 October 2022

complications of pregnancy

1 reference

prenatal exposure delayed effects

21 March 2019

3 references

13 December 2019

1 February 2021

28 October 2022

tumor necrosis factor

2 references

1 August 2019

1 February 2021

1 reference

27 September 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

Edward V Loftus

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Tine Jess

series ordinal

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

1 reference

31 July 2013

12 references

13 March 2019

21 March 2019

19 June 2019

1 August 2019

27 September 2019

20 November 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

1 February 2021

28 October 2022

12 references

13 March 2019

21 March 2019

19 June 2019

1 August 2019

27 September 2019

20 November 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

1 February 2021

28 October 2022

11

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

174

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

6 March 2020

copyright license

10 references

13 March 2019

21 March 2019

19 June 2019

1 August 2019

27 September 2019

20 November 2019

27 November 2019

13 December 2019

1 February 2021

on focus list of Wikimedia project

28 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

VACTERL/VATER Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

21 March 2017

https://api.crossref.org/works/10.1186/1741-7015-11-174

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Use of biological molecules in the treatment of inflammatory bowel disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Inflammatory bowel disease and pregnancy: report of two cases treated with infliximab and a review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

A safety assessment of tumor necrosis factor antagonists during pregnancy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Biologic therapy and pregnancy outcomes in women with rheumatic diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Is infliximab safe to use while breastfeeding?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Pregnancy and nursing in inflammatory bowel disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure

28 September 2017

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

A 24-year-old pregnant woman with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Do tumor necrosis factor inhibitors cause malformations in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Adalimumab use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Certolizumab use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1741-7015-11-174

Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Is safety infliximb during pregnancy in patients with inflammatory bowel disease?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Pregnancy and inflammatory bowel disease: a prospective case-control study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734216

Pregnancy in Crohn's disease

28 November 2018

1 reference

12 December 2020

Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody

1 reference

12 December 2020

Successful use of adalimumab (Humira) for Crohn's disease in pregnancy

1 reference

12 December 2020

Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception

1 reference

12 December 2020

Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study

1 reference

12 December 2020

Successful use of infliximab for perianal Crohnʼs disease in pregnancy

1 reference

12 December 2020

Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease

1 reference

12 December 2020

Infections Associated with Tumor Necrosis Factor-α Antagonists

1 reference

12 December 2020

IBD: Can TNF inhibitors be administered during the third trimester?

1 reference

12 December 2020

Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31

1 reference

12 December 2020

Inadvertent conception during concomitant treatment with infliximab and methotrexate in a patient with Crohn's disease: is the game worth the candle?

1 reference

12 December 2020

Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature

1 reference

12 December 2020

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

1 reference

12 December 2020

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis

1 reference

12 December 2020

Adalimumab level in breast milk of a nursing mother

1 reference

12 December 2020

Pregnancy in ulcerative colitis

1 reference

12 December 2020

Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFalpha monoclonal antibody

1 reference

12 December 2020

Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody)

1 reference

12 December 2020

Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis

1 reference

12 December 2020

Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey

1 reference

12 December 2020

Infliximab treatment and pregnancy outcome in active Crohn's disease

1 reference

12 December 2020

Legionella pneumophila pneumonia in a pregnant woman treated with anti-TNF-α antibodies for Crohn's disease: A case report

1 reference

12 December 2020

The impact of disease activity of Crohn's disease during pregnancy on fetal growth

1 reference

12 December 2020

Inflammatory bowel disease in pregnancy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1741-7015-11-174

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

23902720

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23902720 AND SRC:MED&resulttype=core&format=json